Diplacol , CAS No.76556-05-3

CAS: 76556-05-3 Cat. No.: D1434114 分子式: C25H28O7 分子量: 440.49
注文可能
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
サイズ
USA
ドイツ (EU)*
価格
個数
1mg
D1434114-1mg
受注生産 · 8~12週間
Enter a quantity for the sizes you want to add.

概要

Diplacol is a geranylated flavanone that can be isolated from paulownia trees ( Paulownia coreana UYEKI ). Diplacol has anti-inflammatory activity. Diplacol inhibits NO production in LPS-stimulated Raw264.7 cells with an IC 50 value of 4.53 μM.

仕様

保管条件
Store at -20°C
入荷
Ice chest + Ice pads
この製品は冷冷この冷このこの製品の運送が必要です。地上およびその他の経済サービスは利用できません。
アクションタイプ
INHIBITOR
名前と識別子
分子量
440.49

詳細データ

証明書(CoA、COO、BSE/TSEと分析図)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
ソリューション計算機
レビュー

顧客レビュー

Application Protocols

No item‑specific tested applications are provided. The following generalized protocols are offered for small‑molecule test articles in discovery assays.

  • Stock solution preparation

    • Weigh accurately in a dry environment.
    • Dissolve to 10–20 mM in anhydrous DMSO (or EtOH/MeCN if preferred). Sonicate briefly if needed; avoid heating above 40 °C.
    • Aliquot single‑use volumes (e.g., 10–50 μL) in amber vials/plates; store at −20 °C.
  • Biochemical assay dosing

    • Prepare serial dilutions in assay buffer maintaining constant vehicle (≤0.1–0.5% v/v DMSO final).
    • Include vehicle control and a positive control (if available) on every plate.
  • Cell‑based assay dosing

    • Pre‑check cytotoxicity/viability (e.g., resazurin/ATP readouts) of the vehicle and top test concentration.
    • Add compound last to pre‑equilibrated media; mix thoroughly to avoid localized precipitation.
  • Stability/quality checks

    • Inspect solutions visually for precipitation or color change; confirm by LC–MS/HPLC after 24–48 h at assay conditions.
    • Record lot, stock concentration, and dilution scheme in ELN for traceability.
Biological Roles
  • No biological role, mechanism, or pathway information is provided for this specific item. Do not infer pharmacology without verified structural data and experimental evidence.

General guidance for small‑molecule test articles (non–item-specific)

  • If the structure is known internally, map likely chemotype–target associations using substructure alerts and cheminformatics fingerprints to prioritize assays.
  • Profile pan‑assay interference (PAINS) and reactive functional group risks before biological testing; confirm activity with orthogonal assays and counterscreens.
  • Evaluate chemical stability in assay media (pH, redox, photolysis) and adsorption to plastics; quantify free fraction if high lipophilicity is suspected.
  • Document and report exact solvent percentages and vehicle controls; include cytotoxicity/viability assessments for cell‑based work.

Note

  • This product is supplied strictly for research use only. No statements herein imply therapeutic use or clinical suitability.
Buffer Applications

This compound is not a buffering reagent. However, when used as a test article in buffered biological assays, the following practical considerations apply (general guidance):

  • Prepare concentrated DMSO or EtOH stocks (e.g., 10–20 mM), then dilute into assay buffer (PBS, HEPES, Tris) to a final solvent content typically ≤0.1–0.5% v/v.
  • If precipitation occurs upon dilution, add compound to buffer slowly with vigorous mixing, consider mild heating (≤37 °C) or include 0.01–0.1% nonionic surfactant (e.g., Tween‑20) when assay‑compatible.
  • Maintain constant vehicle % across all wells/tubes, including controls.
  • For pH‑sensitive chemotypes (unknown here), use HEPES (pH 7.4) to minimize temperature‑dependent pKa shifts; avoid high phosphate when performing metal‑dependent enzymology.
  • Filter sterilize (0.22 μm) only if the compound is known to be stable to brief contact with membrane materials; pre‑wet filters with solvent to limit adsorption losses.
Green Alternatives

As a small‑molecule test article, “green” considerations largely center on the choice of dissolution medium and work‑up rather than substituting the compound itself.

Greener dissolution strategies (general)

  • Prefer EtOH, i‑PrOH, or MeCN over chlorinated solvents when feasible.
  • Minimize DMSO carryover in assays by preparing high‑concentration stocks and diluting to ≤0.1–0.5% v/v final.
  • Explore cyclodextrin inclusion or PEG‑400/water co‑solvent systems for difficult solubility cases in aqueous assays.

Comparison of common stock solvents (general)

  • DMSO: Excellent solvency; high boiling point; low volatility; not readily biodegradable; typical final assay ≤0.5% v/v.
  • Ethanol: Renewable feedstock; good aqueous miscibility; may perturb membranes/enzymes at >1–2% v/v.
  • Acetonitrile: LC‑MS compatible; volatile; moderate toxicity but favorable EHS vs chlorinated solvents.
  • Isopropanol: Greener profile; slower evaporation than ethanol; good co‑solvent.

Operational tips to reduce impact

  • Scale down screening volumes (microplates, automated nanoliter dispensing).
  • Reuse clean glassware; avoid single‑use plastics where solvent compatible.
  • Consolidate shipments to reduce cold‑chain footprint and confirm batch suitability before ordering multiples.
Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation use is provided for this item. It is supplied for research use only and is not intended for human or veterinary use.

General R&D context (non–item-specific)

  • In discovery settings, small molecules may be formulated for in vitro and exploratory in vivo studies using standard vehicles (e.g., DMSO/PEG‑400/saline, Captisol, lipid‑based systems) after full structural and safety review. Such activities fall outside the scope of this catalog entry and must follow institutional IACUC/IRB and regulatory guidance.
  • For analytical QC or device testing, compounds can serve as system suitability standards once identity/purity are confirmed.

Do not construe any of the above as clinical guidance. This product is not certified to any pharmacopoeial monograph.

Physical Properties

Item-specific physical constants are not disclosed in this listing.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (literature/spec): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (literature/spec): Not specified for this item; refer to CoA/Spec Sheet.
  • Density (spec): Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD (literature/computed): Not specified for this item; refer to CoA/Spec Sheet.
  • pKa (literature/computed): Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility (spec): Not specified for this item; refer to CoA/Spec Sheet.

General laboratory guidance (non–item-specific)

  • For unknown small molecules, begin solubility screening with anhydrous DMSO, DMF, MeCN, EtOH/MeOH, and buffered aqueous media (pH 6.5–7.4). Escalate with gentle warming (≤40 °C) and brief sonication; avoid prolonged heating until thermal profile is known.
  • For NMR: trial in CDCl3, DMSO‑d6, MeOD‑d4, or CD3CN; select based on observed solubility and chemical stability (watch for hydrolysis or acetal/ester cleavage in protic media).
  • For chromatographic method development, start with reverse‑phase C18 (water/acetonitrile + 0.1% formic acid or ammonium acetate) and adjust pH/organic content based on retention and ionization behavior.
  • If hygroscopicity or polymorphism is suspected, equilibrate samples in a dry box and document thermal transitions by DSC/TGA prior to weighing for quantitative studies.
Quality and Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and expectations

  • For small‑molecule library members, suppliers typically control identity by NMR/HRMS and purity by HPLC/UPLC. Unless otherwise stated on the CoA, do not assume a particular assay (e.g., Karl Fischer, residual solvent panel, chiral purity).
  • If your application is biological screening or biophysical binding, consider requesting lots with ≥95% HPLC purity and a current CoA that includes purity method details (wavelengths, gradient, reference standards) to ensure comparability across campaigns.
  • If your application is analytical reference or calibration, request impurity profiling and confirmed water content/residual solvent data.
  • Stabilizers/inhibitors: Not specified for this item; refer to CoA/Spec Sheet. If stabilizers are present, they may influence UV baselines and bioassays; account for these in blanks/controls.

Batch control & documentation

  • Record lot number at first use; archive the CoA and SDS with your ELN entry.
  • If you require special grades (HPLC/LC–MS grade solvent compatibility, salt form consistency, polymorph control), contact technical support with your specification before ordering.
Reaction and Applications

This product is offered primarily as a research library small molecule rather than as a general synthetic reagent. No manufacturer‑provided application notes are available for this entry.

Typical research uses (general, non–item-specific)

  • Primary/secondary screening: Evaluate as a test article in biochemical or cell‑based assays to explore target modulation, phenotypic effects, or probe development potential.
  • Reference/control material: Serve as a comparator in analytical method development (e.g., LC–MS retention/ionization benchmarking) once structure is confirmed.
  • Biophysical characterization: Assess binding via DSF, MST, ITC, SPR, NMR depending on solubility and stability.
  • ADME profiling (discovery context): Solubility, permeability, microsomal stability, and plasma protein binding screens when structure is known and permitted by internal governance.

If used in synthesis (only after structure is verified)

  • Consider protecting groups and chemoselectivity guided by functional motifs revealed on the CoA/structure. Establish stability to acids/bases/oxidants before multi‑step usage.

Documentation

  • Record exact lot, solvent system, and concentration in all assay records to ensure reproducibility and traceability.
Reaction Conditions

No standard reaction conditions apply because this product is not supplied as a reagent for a specific named transformation and the structure is not provided here.

General, non–item-specific guidance if chemical modification is attempted after structure confirmation

  • Solvents: start with dry MeCN, DMF, DCM, THF, or EtOAc as dictated by functionality; for metal‑catalyzed steps, ensure anhydrous, oxygen‑free conditions.
  • Temperatures: explore 0–80 °C for most polar reactions; limit to ≤40 °C if thermal lability is suspected and monitor by LC–MS.
  • Catalysts/bases: choose mild bases (DIPEA, K2CO3) and Pd catalysts (for cross‑couplings) only after verifying compatibility with other motifs (e.g., sulfur heterocycles can poison catalysts).
  • Work‑up: quench carefully, extract with greener solvents when possible (EtOAc/MTBE), and avoid silica overexposure for acid‑labile compounds; consider neutral alumina.

Always validate each step with small‑scale pilots before committing precious library material.

Safety and Handling

Safety data specific to this item are not listed here; consult the SDS for authoritative information.

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal Word / H‑Statements / Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (good practice)

  • Handle in a chemical fume hood with standard PPE: lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Avoid inhalation of dusts/aerosols and contact with skin/eyes.
  • Until compatibility is known, segregate from strong oxidizers, strong acids/bases, and reducing agents. Use inert atmosphere (N2/Ar) if air/moisture sensitivity is suspected.
  • Prevent cross‑contamination: dedicate spatulas/scoops; close vials promptly; minimize freeze–thaw.
  • First aid (overview; defer to SDS): rinse skin/eyes with water for ≥15 min upon contact; move to fresh air if inhaled; seek medical attention if symptoms persist.
  • Spill response: avoid dust generation; cover with inert absorbent; collect in sealed container for disposal per local regulations.
  • Waste: dispose as organic chemical waste in accordance with institutional and governmental regulations.
  • Shipping/receipt: this product is shipped cold; verify cold chain on receipt and return to specified storage (-20 °C).
Solvent Selection

With structure not disclosed here, select solvents pragmatically based on solubility and intended use (screening vs. synthesis vs. analytics).

  • Primary stock solvent (typical): DMSO for biological assays due to broad solubilizing power and cell‑compatibility at low % v/v.
  • Alternative organic media: DMF, N‑MP, MeCN, EtOH/MeOH, isopropanol. For water‑insoluble compounds, co‑solvent systems (DMSO or EtOH + buffer) are common.
  • Aqueous work: If aqueous use is required, evaluate pH 6.5–7.4 buffers (HEPES, PBS) and add ≤0.5–1% v/v DMSO or up to 10–20% v/v MeCN/EtOH as needed. Consider surfactants (0.01–0.1% Tween‑20) or carriers (0.1% BSA) to mitigate adsorption.
  • NMR solvents: CDCl3, DMSO‑d6, MeOD‑d4, CD3CN. Choose based on observed stability/solubility.

Quick comparison (general)

  • DMSO: strongest solubilizer; hygroscopic; high b.p.; can affect some targets above 0.5%.
  • MeCN: LC‑MS friendly; moderate solvency; volatile.
  • EtOH/IPA: greener profile; good miscibility with water; may affect membranes/enzymes at higher %.

Practical tips

  • Start with a 10–20 mM DMSO stock; check clarity after brief sonication. Filter (0.2 μm PTFE) if particulates persist.
  • Avoid excessive heating and extreme pH until chemical stability is established by LC–MS.
Storage and Reconstitution
  • Storage Conditions (as provided): Store at −20 °C. Keep tightly closed in the original container. Protect from moisture and prolonged light exposure until stability is known.
  • Shipped In: Ice chest + ice pads (cold chain). Inspect upon receipt; return to −20 °C promptly.

Reconstitution (general guidance)

  • Allow vial to warm to room temperature in a desiccator before opening to minimize moisture uptake/condensation.
  • Prepare concentrated stocks (e.g., 10–20 mM) in anhydrous DMSO or another validated solvent. Mix gently and briefly sonicate if required. Avoid repeated heating/cooling cycles.
  • Aliquoting: Divide into single‑use portions in inert vials or low‑bind microtubes; purge headspace with nitrogen/argon if the compound is air‑ or moisture‑sensitive (unknown here).
  • Freeze–thaw: Avoid multiple freeze–thaw cycles. Thaw aliquots only once; discard leftovers to maintain consistency across experiments.
  • Long‑term stability: Not specified for this item; refer to CoA/Spec Sheet. Users should verify stability by periodic HPLC/LC‑MS checks during storage.

Label all aliquots with compound name, lot number, concentration, solvent, and date of preparation to ensure full traceability.

Structure and Identity

Concise identity summary for a small-molecule library member supplied for research screening and method development.

  • SKU: D1434114
  • Product Name: Diplacol
  • CAS: 76556-05-3
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Structural features

  • Item-specific structural descriptors (ring systems, functional groups, stereochemistry) are not provided in the current listing. Consult the product CoA/SDS or request the specification sheet for exact structural representation.

Professional guidance (general)

  • For in-house verification, confirm identity by orthogonal techniques such as: 1H/13C NMR, HRMS (ESI/APCI as appropriate), and HPLC/UPLC purity profiling. Where possible, acquire IR and, if crystalline, single-crystal XRD.
  • If only CAS is available, cross-check with trusted databases in addition to the Aladdin CoA to ensure consistent structure assignment before initiating SAR or biological studies.
Synthetic Utility

Specific functional groups and reactivity cannot be described without the disclosed structure. Based on its positioning in a small‑molecule library, the compound is not primarily offered as a synthetic building block but as a test article.

General considerations if derivatization is planned (non–item-specific)

  • Once structure is confirmed, map reactive handles (halides, heteroatoms, carbonyls) and assess chemoselectivity under common transformations (e.g., cross‑coupling, amide formation, N‑alkylation, reductive amination).
  • Establish stability domains (acid/base/redox/thermal) before scale‑up. Run micro‑scale scouts (0.01–0.05 mmol) with LC–MS monitoring to avoid material loss.
  • If chirality is present, determine enantiopurity and racemization risk; choose mild coupling/oxidation conditions accordingly. Consider chiral HPLC or SFC for resolution.
  • For SAR exploration, design analogue‑friendly vectors (positions tolerant to modification) using docking or matched molecular pair analysis once biological data emerge.

Documentation

  • Maintain complete analytical records (NMR, LC–MS, HPLC purity, water content if relevant) for both parent and derivatives to support reproducibility and IP filings.
Target Specificity

No target, mechanism of action, selectivity profile, or bioassay validation is provided for this item. It is not an antibody or biologic; therefore, epitope/clone/isotype details are not applicable.

If used as a tool compound (general guidance)

  • Establish on‑target activity with at least two orthogonal assays and include counterscreens to deconvolute off‑target or assay‑interference effects.
  • Determine concentration–response curves and report Hill slopes alongside IC50/EC50. Confirm reproducibility across lots and assay days.

よくある質問

What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.